CD274 and cancer: In contrast to other cancers, however, we and others have demonstrated that the expression of PD-1 or its ligand PD-L1 (CD274, B7-H1) are not independent prognostic markers for glioblastoma patients [35,36,37] and are relatively low in expression compared to other cancers [36,37,38].